TPP-resveratrol
TPP-resveratrol is a conjugate of Resveratrol (HY-16561) and triphenylphosphine (TPP) with anticancer activity. TPP-resveratrol increases the potency of Resveratrol through mitochondrial-targeted delivery and induces mitochondria-mediated apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tpp-resveratrol.html
Purity
99.76
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(CCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OC4=CC(O)=CC(/C=C/C5=CC=C(C=C5)O)=C4.[Br-]
Molecular Formula
C36H32BrO4P
Molecular Weight
639.51
References & Citations
[1]Jiang L, et al. The anti-cancer effects of mitochondrial-targeted triphenylphosphonium–resveratrol conjugate on breast cancer cells[J]. Pharmaceuticals, 2022, 15 (10) : 1271.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY415916 100 µg
HNRPH3 (HNRNPH3) (NM_012207) Human Over-expression Lysate
Sign In for Pricing
View Details 
128713-ML650 100 µL
Kallikrein 4 (Kallikrein-4, Enamel Matrix Serine Proteinase 1, Kallikrein-like Protein 1, KLK-L1, Prostase, Serine Protease 17, EMSP1, PRSS17, PSTS) (MaxLight 650)
Sign In for Pricing
View Details GTR15181967 1 Vial
Lentiviral mouse Mmaa shRNA (UAS) - Lentiviral mouse Mmaa shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details